Oscillo Biosciences, a biotech company, aims to preserve and restore memory and cognition in people with Alzheimer’s disease and dementias.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 29, 2020 | Grant | $224.84K | 1 |
![]() |
— | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
![]() |
Yes | Grant |